Related Experiment Video

Updated: Jun 27, 2026

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
08:57

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Published on: October 6, 2019

Transcriptional regulation of IRS5/DOK4 expression in non-small-cell lung cancer cells

Steven G Gray1, Nael Al-Sarraf, Anne-Marie Baird

  • 1Department of Clinical Medicine, Thoracic Oncology Research Group, Institute of Molecular Medicine, Trinity Centre for Health Sciences, Dublin 8, Ireland.

Clinical Lung Cancer
|December 17, 2008
PubMed

Insights

Altered expression of IRS5/Dok4 occurs in non-small-cell lung cancer (NSCLC). Epigenetic regulation via chromatin remodeling and hypoxia influences IRS5/DOK4 levels, suggesting potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • The insulin-receptor substrate (IRS) family is crucial for cellular processes.
  • IRS5/Dok4 and IRS6/Dok5 are newly identified IRS family members.
  • Altered gene expression is a hallmark of non-small-cell lung cancer (NSCLC).

Purpose of the Study:

  • To investigate the expression patterns of IRS5/Dok4 in NSCLC.
  • To explore the regulatory mechanisms of IRS5/Dok4 expression in lung cancer.
  • To assess the impact of epigenetic modifiers and hypoxia on IRS5/DOK4.

Main Methods:

  • Analysis of IRS5/DOK4 expression in NSCLC cell lines and tumor specimens.
  • Investigation of methylation status at the IRS5/DOK4 locus.
  • Treatment of NSCLC cells with trichostatin A (TSA) and assessment of IRS5/DOK4 levels.
  • Chromatin immunoprecipitation (ChIP) to evaluate histone acetylation at the IRS5/DOK4 promoter.
  • Exposure of cells to hypoxia and subsequent analysis of IRS5/DOK4 expression.

Main Results:

  • IRS5/DOK4 expression is frequently altered (upregulated and downregulated) in NSCLC tumors.
  • Aberrant methylation does not account for the altered IRS5/DOK4 expression.
  • Trichostatin A (TSA) treatment upregulates IRS5/DOK4 expression in NSCLC cell lines.
  • ChIP assays confirm TSA-induced histone hyperacetylation at the IRS5/DOK4 promoter.
  • Hypoxia downregulates IRS5/DOK4 expression, an effect reversed by TSA.

Conclusions:

  • IRS5/DOK4 expression is epigenetically regulated in NSCLC, primarily through chromatin remodeling.
  • Histone deacetylase inhibition (e.g., TSA) can restore IRS5/DOK4 expression.
  • Hypoxia-induced downregulation of IRS5/DOK4 is reversible.
  • The clinical significance of IRS5/DOK4 alterations in NSCLC warrants further investigation.

More Related Videos

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice08:09

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF311:44

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

Published on: January 24, 2016

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...